Comparative phenotypic and genotypic analysis of distinct Pseudomonas aeruginosa T3SS effector genotypes

Nada K Alharbi1, Naser A El-Sawy2, Naief A Dahran3

  • 1Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Abstract

Insights

Pseudomonas aeruginosa infections are diverse, with type III secretion system (T3SS) effector genotypes like exoU+ predicting severe disease. Resistance is common, but polymyxin remains effective, highlighting T3SS profiling for risk assessment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Pseudomonas aeruginosa causes diverse infections with significant antimicrobial resistance.
  • Type III secretion system (T3SS) effectors are key virulence factors, but their associations with resistance and clinical outcomes are unclear.

Purpose of the Study:

  • To investigate the relationships between T3SS effector genotypes, antimicrobial resistance, virulence factors, serotypes, and clinical manifestations of P. aeruginosa infections.
  • To assess the population structure and identify predictors of disease severity in P. aeruginosa.

Main Methods:

  • Collected 500 clinical isolates of P. aeruginosa from various specimen types.
  • Characterized isolates for T3SS effector genotypes (exoS, exoU, exoT, exoY), antimicrobial susceptibility, resistance and virulence genes, and serotypes.
  • Utilized clustering and correlation analyses to assess associations between resistance, virulence, epidemiology, and disease severity.

Main Results:

  • ExoS+ was the most prevalent T3SS effector genotype; exoU+ isolates were linked to severe disease and hospital acquisition.
  • Antimicrobial resistance was widespread, with polymyxin being the most effective agent.
  • Isolates showed heterogeneity, with weak associations between resistance, virulence, serotypes, and epidemiology, except for exoU+ and severe tissue injury.

Conclusions:

  • P. aeruginosa populations are heterogeneous, with independent resistance and virulence traits.
  • T3SS effector genotypes, particularly exoU+, are strong predictors of disease severity.
  • Integrating T3SS effector profiling into clinical risk assessment and surveillance is recommended.